Page 96 - GALENIKA MEDICAL JOURNAL

Zaključak

Aktuelni vodič ima izvjesne razlike u odnosu na vodič iz 2016. i daje nove preporuke i smjernice
koje je potrebno implementirati u praksi da bismo ostvarili benefit u liječenju pacijenata, smanjili
mortalitet, morbiditet, broj hospitalizacija i poboljšali kvalitet života pacijenata.

Abstract

Heart failure (HF) is a global health problem nowadays, with a high prevalence and incidence rate, as like as a high mortality
rate. Quality of life is also very important for patients and their families, and it is often affected in HF. This article is not
only about a definition and different types of HF, it is more about modern diagnostic and therapeutic approaches to HF
patients according to the latest ESC guidelines for the diagnosis and treatment of acute and chronic HF. There are many
different factors contributing to poor quality of life in HF. The last ESC HF guidelines have recognized the importance of
multidiciplinar approach to HF patients, such as treatment of cardiovascular and non-cardiovascular comorbidities.

Keywords: guidelines, heart failure, diagnosis, treatment

Literatura 7. Vaduganathan M, Claggett BL, Jhund PS, Cunningham JW, Pedro
Ferreira J, Zannad F, et al. Estimating lifetime benefits of comprehensive
disease-modifying pharmacological therapies in patients with heart
1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm failure with reduced ejection fraction: a comparative analysis of three
M, et al; ESC Scientific Document Group. 2021 ESC Guidelines for the randomised controlled trials. Lancet. 2020 Jul 11;396(10244):121-8.
diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 8. Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, et al.
2021 Sep 21;42(36):3599-726.
SGLT2 inhibitors in patients with heart failure with reduced ejection
2. SEC Working Group for the 2021 ESC guidelines for the diagnosis fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
and treatment of acute and chronic heart failure and SEC Guidelines Lancet. 2020 Sep 19;396(10254):819-29.
Committee. Comments on the 2021 ESC guidelines for the diagnosis 9. Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, et
and treatment of acute and chronic heart failure. Rev Esp Cardiol (Engl al; EMPEROR-Preserved Trial Investigators. Empagliflozin in Heart
Ed). 2022 Jun;75(6):458-65.
Failure with a Preserved Ejection Fraction. N Engl J Med. 2021 Oct
3. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al; 14;385(16):1451-61.
ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis
and treatment of acute and chronic heart failure: The Task Force for 10. Di Marco A, Brown PF, Bradley J, Nucifora G, Claver E, de Frutos F, et al.
the diagnosis and treatment of acute and chronic heart failure of Improved Risk Stratification for Ventricular Arrhythmias and Sudden
the European Society of Cardiology (ESC)Developed with the special Death in Patients With Nonischemic Dilated Cardiomyopathy. J Am Coll
contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart Cardiol. 2021 Jun 15;77(23):2890-905.
J. 2016 Jul 14;37(27):2129-200. 11. Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash
4. Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert IM, et al; ESC Scientific Document Group. 2021 ESC Guidelines on
cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021
N, et al. Universal definition and classification of heart failure: a report Sep 14;42(35):3427-520.
of the Heart Failure Society of America, Heart Failure Association of
the European Society of Cardiology, Japanese Heart Failure Society 12. Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al;
and Writing Committee of the Universal Definition of Heart Failure: COAPT Investigators. Transcatheter Mitral-Valve Repair in Patients with
Endorsed by the Canadian Heart Failure Society, Heart Failure Heart Failure. N Engl J Med. 2018 Dec 13;379(24):2307-18.
Association of India, Cardiac Society of Australia and New Zealand, and
Chinese Heart Failure Association. Eur J Heart Fail. 2021 Mar;23(3):352-
80.
5. Rosano GMC, Moura B, Metra M, Böhm M, Bauersachs J, Ben Gal T, Konflikt interesa: Nema
et al. Patient profiling in heart failure for tailoring medical therapy. A
consensus document of the Heart Failure Association of the European Primljeno: 05. 12. 2022.
Society of Cardiology. Eur J Heart Fail. 2021 Jun;23(6):872-81.
Prihvaćeno: 28. 12. 2022.
6. Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Onlajn: 01. 03. 2023.
Cleland JGF, et al. Clinical practice update on heart failure 2019:
pharmacotherapy, procedures, devices and patient management. An
expert consensus meeting report of the Heart Failure Association of the
European Society of Cardiology. Eur J Heart Fail. 2019 Oct;21(10):1169-
86.

94 DOI: 10.5937/Galmed2305091D